Krystal Biotech (KRYS) Leases: 2021-2025
Historic Leases for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $7.4 million.
- Krystal Biotech's Leases rose 15.08% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 15.08%. This contributed to the annual value of $6.3 million for FY2024, which is 10.63% down from last year.
- According to the latest figures from Q3 2025, Krystal Biotech's Leases is $7.4 million, which was down 2.72% from $7.7 million recorded in Q2 2025.
- In the past 5 years, Krystal Biotech's Leases ranged from a high of $8.5 million in Q1 2022 and a low of $3.2 million during Q1 2021.
- In the last 3 years, Krystal Biotech's Leases had a median value of $7.4 million in 2023 and averaged $7.2 million.
- Per our database at Business Quant, Krystal Biotech's Leases surged by 164.16% in 2022 and then fell by 12.62% in 2023.
- Over the past 5 years, Krystal Biotech's Leases (Quarterly) stood at $7.2 million in 2021, then rose by 11.26% to $8.0 million in 2022, then dropped by 12.62% to $7.0 million in 2023, then declined by 10.63% to $6.3 million in 2024, then grew by 15.08% to $7.4 million in 2025.
- Its Leases stands at $7.4 million for Q3 2025, versus $7.7 million for Q2 2025 and $7.9 million for Q1 2025.